Factor X - Bio Products Laboratory

Drug Profile

Factor X - Bio Products Laboratory

Alternative Names: Coagadex

Latest Information Update: 14 Jul 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bio Products Laboratory
  • Class Antihaemorrhagics; Blood coagulation factors; Coagulants
  • Mechanism of Action Blood coagulation factor replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Factor X deficiency
  • New Molecular Entity No

Highest Development Phases

  • Marketed Factor X deficiency

Most Recent Events

  • 13 Jul 2017 Adverse events and efficacy data from a phase III trial in Factor X deficiency released by Bio Products Laboratory
  • 01 Oct 2016 Bio Products Laboratory completes a phase-III clinical trial in Factor X deficiency (Prevention, In children, In infants, In neonates) in United Kingdom (IV) (NCT01721681)
  • 06 Jun 2016 Launched for Factor X deficiency in United Kingdom (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top